Monashee Investment Management »

89bio shares owned by Monashee Investment Management

Quarter-by-quarter ownership of 89bio (ETNB) shares owned by Monashee Investment Management from 13F filings

Historical chart of Monashee Investment Management investment in 89bio

Tip: Access up to 7 years of quarterly data

All positions including 89bio held by Monashee Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 89bio by Monashee Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.6M 140k 11.17
2023-03-31 $1.1M 75k 15.23
2020-09-30 $1.0M 40k 25.65

More positions owned by Monashee Investment Management

Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Core S&p Ttl Stk (ITOT)
Vanguard Index Fds Total Stk Mkt (VTI)
Structure Therapeutics Sponsored Ads (GPCR)
Aercap Holdings Nv SHS (AER)
PG&E Corporation (PCG)
Korro Bio (KRRO)
Eyepoint Pharmaceuticals Com New (EYPT)
Celldex Therapeutics Com New (CLDX)
Roivant Sciences SHS (ROIV)

View all positions for Monashee Investment Management

Top funds holding 89bio

RA Capital Management
Henderson Group
Vanguard Group
BVF
Holocene Advisors
Laurion Capital Management
Citadel Advisors
Frazier Life Sciences Management
Redmile Group
Federated Investors
Westfield Capital Management Company
Superstring Capital Management
Franklin Resources
Orchard Capital Managment
Caption Management

View all funds holding 89bio